IDiyas

For the Inventor, By the Inventor

Whippany, NJ, United States of America

Min K Park

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 9.5

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Whippany, NJ (US) (2002 - 2022)
  • Morristown, NJ (US) (2019 - 2022)

Company Filing History:

goldMedal8 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal6 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 2002-2022

Loading Chart...
Loading Chart...
14 patents (USPTO):
1. 11433055 - Chromane monobactam compounds for the treatment of bacterial infections (2022-09-06),
2. 11230543 - Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections (2022-01-25),
3. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes (2019-10-15),
4. 10399972 - Tricyclic compounds as inhibitors of mutant IDH enzymes (2019-09-03),
5. 9844553 - Pyrazolopyridyl compounds as aldosterone synthase inhibitors (2017-12-19),
6. 9518055 - Imidazopyridyl compounds as aldosterone synthase inhibitors (2016-12-13),
7. 9382226 - Aldosterone synthase inhibitors (2016-07-05),
8. 9351973 - Pyrazolopyridyl compounds as aldosterone synthase inhibitors (2016-05-31),
9. 7572822 - Biaryl substituted triazoles as sodium channel blockers (2009-08-11),
10. 7459475 - Substituted triazoles as sodium channel blockers (2008-12-02),
11. 7414057 - Piperazine urea derivatives as melanocortin-4 receptor agonists (2008-08-19),
12. 7326726 - Biaryl substituted triazoles as sodium channel blockers (2008-02-05),
13. 6767915 - Substituted piperidines as melanocortin receptor agonists (2004-07-27),
14. 6458790 - Substituted piperidines as melanocortin receptor agonists (2002-10-01),

Title: Unveiling the Inventive Journey of Min K Park

Introduction:

Min K Park, an esteemed inventor based in Whippany, NJ, USA, has made significant strides in the field of pharmaceuticals with his innovative patented compounds for treating bacterial infections. With a remarkable track record of 14 patents, Min K Park continues to push the boundaries of scientific discovery.

Latest Patents:

1. Chromane monobactam compounds for the treatment of bacterial infections - Min K Park's groundbreaking invention of monobactam compounds has paved the way for novel treatments against bacterial infections. These compounds, with their unique formula, show promise in combatting pathogens effectively.

2. Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections - His inventive biaryl monobactam compounds offer a new perspective on battling bacterial infections. With defined compositions and methods, these compounds demonstrate potential in enhancing the efficacy of antibiotics.

Career Highlights:

Min K Park's expertise has been honed through his tenure at renowned companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His contributions have not only enriched these organizations but have also left a lasting impact on the pharmaceutical industry.

Collaborations:

Collaborating with talented individuals like Brenda L Palucki and Xianhai Huang has been instrumental in Min K Park's inventive journey. Through synergistic teamwork and shared passion for innovation, they have collectively advanced the frontiers of pharmaceutical research and development.

Conclusion:

In conclusion, Min K Park's dedication to scientific pioneering in the realm of bacterial infection treatments is truly commendable. His patents stand as a testament to his ingenuity and commitment to improving healthcare outcomes. As he continues to innovate and collaborate, the future holds great promise for further revolutionary advancements in the field, all thanks to inventive minds like Min K Park.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…